Analysis and Impact of Formulated Herbal Medicine Against COVID-19 and Other Viral Infections
Herbal drugs play significant role in the India and many parts of the world to cure many diseases and health complications. These drugs are used to treat viral, bacterial and many other microbial diseases viz. COVID-19, dengue, malaria, cancer and diabetes. Still herbal drug is not achieved prominent place in the health system. This study highlights the significant role of herbal medicine Chronheal-7 to cure COVID-19, dengue, malaria and other microbial infections. Chronheal-7, poly herbal medicine prepared from six different herbs, G. glabra, P. niruri, S. xanthocarpum, B. diffusa, E. alba and W. somnifera. Chronheal-7 effect against SARS-CoV-2 is endorsed by In Vivo and In Vitro studies. Ayurvedic polyherbal formulation "Chronheal-7" has shown great potential against viral infections COVID-19 including dengue and chikungunya. The results obtained by In Vitro and In Vivo antiviral studies showed 'Chronheal-7' potential against SARS-CoV-2 virus. COVID-19, dengue and chikungunya infected patients cured by 'Chronheal-7' medicine. SARS-CoV-2 virus infected VeroE6 cell line assay showed anti-viral potential of ‘Chronheal-7’ (49.45% inhibition) after 30 h of incubation and cytotoxicity test showed non-toxicity for human cells. In Vitro and In Vivo studies showed 'Chronheal-7' medicine is effective against COVID-19 along with other viral infections viz. dengue, chikungunya. Chronheal-7 has great potential for management of COVID-19 and microbial aliments. It can be used as one of the immune-modular herbal drug in different viral infections. The authors claim that the Chronheal-7 is antiviral and antimicrobial herbal medicine. This study confirms the antiviral effects of Chronheal-7 on the key human pathogen SARS-CoV-2 and may be used as special drug to cure many viral, bacterial and fungal infections.
Authors
- Shruti Kate (ORCID: https://orcid.org/0000-0003-0431-8588)
- Vishal Vilas Dawka
Publication Details
- Journal
- ChemSci advances.
- Published
- 2024-09-01
- DOI
- https://doi.org/10.69626/csa.2024.0120
- Primary Topic
- Medicinal Plants and Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00